Latest Close
$132.63
News
ABVX
Abivax SA News
This news view pulls recent coverage and headlines tied to ABVX.
1y Change
$126.61 (+2103.16%)
Market Cap
$10.57B
Sector
Healthcare
Industry
Biotechnology
Recommendation
strong_buy
What Makes Abivax SA Sponsored ADR (ABVX) a Strong Momentum Stock: Buy Now?
Zacks • May 28, 2026
Read articleABIVAX Société Anonyme (ENXTPA:ABVX) Is Up 6.9% After Long-Term Obefazimod Data And Q1 Results - Has The Bull Case Changed?
Simply Wall St. • May 24, 2026
Read articleAbivax Presents First Quarter 2026 Financial Results and Reports Three-Year Interim Data from Study 108, a Phase 2a/2b Open-Label Extension Trial of Obefazimod Following Dose De-Escalation in Patients with Ulcerative Colitis
GlobeNewswire • May 22, 2026
Read article2 Stocks That Could Realistically Double by 2030
Motley Fool • May 22, 2026
Read articleDyne Therapeutics Is Up 40%, but One Biotech Fund Just Disclosed Selling $14 Million Worth of Shares
Motley Fool • May 19, 2026
Read articleWhat This Fund’s $14 Million Ocular Therapeutix Exit Could Signal for Investors
Motley Fool • May 19, 2026
Read article